Mercer Global Advisors Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
340Shares Held
101MCall Options Held
979KPut Options Held
496K-
Vanguard Group Inc Valley Forge, PA16MShares$660 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.7MShares$645 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.9MShares$448 Million5.14% of portfolio
-
State Street Corp Boston, MA6.4MShares$263 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.98MShares$205 Million3.21% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.35B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...